These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 16276823)
1. [C-reactive protein in patients with coronary heart disease]. Rajtar R; Kolasińska-Kloch W; Kloch M Folia Med Cracov; 2004; 45(1-2):25-32. PubMed ID: 16276823 [TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the Centers for Disease Control/American Heart Association high-sensitivity C-reactive protein cut points for cardiovascular and other outcomes in patients with stable coronary artery disease. Sabatine MS; Morrow DA; Jablonski KA; Rice MM; Warnica JW; Domanski MJ; Hsia J; Gersh BJ; Rifai N; Ridker PM; Pfeffer MA; Braunwald E; Circulation; 2007 Mar; 115(12):1528-36. PubMed ID: 17372173 [TBL] [Abstract][Full Text] [Related]
3. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients. Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079 [TBL] [Abstract][Full Text] [Related]
4. High sensitive C-reactive protein: a novel biochemical markers and its role in coronary artery disease. Mitra B; Panja M J Assoc Physicians India; 2005 Jan; 53():25-32. PubMed ID: 15857009 [TBL] [Abstract][Full Text] [Related]
5. C-reactive protein: a new risk assessment tool for cardiovascular disease. Clearfield MB J Am Osteopath Assoc; 2005 Sep; 105(9):409-16. PubMed ID: 16239491 [TBL] [Abstract][Full Text] [Related]
6. Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients. Kanwar M; Hashem M; Rosman H; Kamalakannan D; Cheema A; Ali A; Gardin J; Maciejko JJ Am J Cardiol; 2006 Nov; 98(9):1283-7. PubMed ID: 17056347 [TBL] [Abstract][Full Text] [Related]
7. [C-reactive protein potential risk factor for cardiovascular disease]. Tornvall P; Pernow J; Hansson LO Lakartidningen; 2003 Aug; 100(35):2691-3. PubMed ID: 14531129 [TBL] [Abstract][Full Text] [Related]
8. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention. Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394 [TBL] [Abstract][Full Text] [Related]
10. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170 [TBL] [Abstract][Full Text] [Related]
11. [Inflammation and C-reactive protein in cardiovascular disease]. Munk PS; Larsen AI Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445 [TBL] [Abstract][Full Text] [Related]
12. High-sensitivity C-reactive protein is the most effective prognostic measurement of acute coronary events. Futterman LG; Lemberg L Am J Crit Care; 2002 Sep; 11(5):482-6. PubMed ID: 12233975 [TBL] [Abstract][Full Text] [Related]
13. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris. Gach O; Legrand V; Biessaux Y; Chapelle JP; Vanbelle S; Pierard LA Am J Cardiol; 2007 Jan; 99(1):31-5. PubMed ID: 17196457 [TBL] [Abstract][Full Text] [Related]
14. Additive value of immunoassay-measured fibrinogen and high-sensitivity C-reactive protein levels for predicting incident cardiovascular events. Mora S; Rifai N; Buring JE; Ridker PM Circulation; 2006 Aug; 114(5):381-7. PubMed ID: 16864722 [TBL] [Abstract][Full Text] [Related]
15. How to use the C-reactive protein in cardiac disease? Ursella S; Mazzone M; Portale G; Testa A; Pignataro G; Covino M; Fenici P; Gasbarrini GB; Gentiloni Silveri N Minerva Cardioangiol; 2005 Feb; 53(1):59-68. PubMed ID: 15788980 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting. van der Harst P; Voors AA; Volbeda M; Buikema H; van Veldhuisen DJ; van Gilst WH Am J Cardiol; 2006 Jun; 97(12):1697-701. PubMed ID: 16765116 [TBL] [Abstract][Full Text] [Related]
18. Clinical implications of C-reactive protein as a predictor of vascular risk. Katrinchak C; Fritz K J Am Acad Nurse Pract; 2007 Jul; 19(7):335-40. PubMed ID: 17680898 [TBL] [Abstract][Full Text] [Related]
19. [C-reactive protein: cardiovascular issues of an acute-phase protein]. Amezcua-Guerra LM; Springall del Villar R; Bojalil Parra R Arch Cardiol Mex; 2007; 77(1):58-66. PubMed ID: 17500194 [TBL] [Abstract][Full Text] [Related]
20. The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome. Yang J; Li XP; Zhao SP; Li J; Li JD; Xie XM Clin Chim Acta; 2006 Jun; 368(1-2):183-7. PubMed ID: 16472797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]